Saúde da Criança e do Adolescente, Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brazil.
J Pediatr (Rio J). 2010 Sep-Oct;86(5):384-90. doi: 10.2223/JPED.2022. Epub 2010 Aug 23.
To investigate the medium-term benefits of a swimming program in schoolchildren and adolescents with moderate persistent atopic asthma (MPAA).
A randomized, prospective study of children and adolescents (age 7-18 years) with MPAA was carried out at the Hospital de Clínicas of Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil. After a 1-month run-in period, 61 patients (34 female) were randomized into two groups, a swimming group (n = 30) and a control group (n = 31), and followed for 3 months. Both patient groups received inhaled fluticasone (dry powder, 250 mcg twice a day) and salbutamol as needed. The swim training program consisted of two weekly classes over a 3-month period for a total of 24 sessions. Both groups underwent spirometric assessment and methacholine challenge test--provocative concentration of methacholine causing a 20% fall in FEV1 (PC₂₀)--before and after the study period. Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) were measured only in the swimming group.
Significant increases in PC₂₀ (pre-training, 0.31±0.25; post-training, 0.63±0.78; p = 0.008), MIP (pre-training, 67.08±17.13 cm H₂O; post-training 79.46±18.66; p < 0.001), and MEP (pre-training, 71.69±20.01 cm H₂O; post-training, 78.92±21.45 cm H₂O; p < 0.001) were found in the swimming group.
Children and adolescents with MPAA subjected to a swim training program experienced a significant decrease in bronchial hyperresponsiveness, as determined by increased PC₂₀ values, when compared with asthmatic controls who did not undergo swim training. Participants in the swimming group also showed improvement in elastic recoil of the chest wall.
研究游泳项目对患有中度持续性特应性哮喘(MPAA)的儿童和青少年的中期益处。
巴西坎皮纳斯州立大学临床医院(UNICAMP)进行了一项针对患有 MPAA 的儿童和青少年(7-18 岁)的随机、前瞻性研究。在为期 1 个月的导入期后,将 61 名患者(34 名女性)随机分为游泳组(n=30)和对照组(n=31),并随访 3 个月。两组患者均接受吸入布地奈德(干粉,每天两次 250 mcg)和按需沙丁胺醇治疗。游泳训练方案包括为期 3 个月的每周 2 次课程,共 24 次。所有患者在研究前后均接受了肺量计评估和乙酰甲胆碱挑战测试-引起 FEV1 下降 20%的乙酰甲胆碱激发浓度(PC₂₀)。仅在游泳组测量最大吸气压力(MIP)和最大呼气压力(MEP)。
游泳组患者的 PC₂₀(基线,0.31±0.25;训练后,0.63±0.78;p=0.008)、MIP(基线,67.08±17.13 cm H₂O;训练后,79.46±18.66;p<0.001)和 MEP(基线,71.69±20.01 cm H₂O;训练后,78.92±21.45 cm H₂O;p<0.001)均显著增加。
与未接受游泳训练的哮喘对照组相比,接受游泳训练的 MPAA 儿童和青少年的支气管高反应性显著降低,表现为 PC₂₀ 值增加。游泳组参与者的胸壁弹性回缩也有所改善。